甲状腺结节细针穿刺分子标志物的研究进展

Progress on molecular markers of fine needle aspiration biopsy of thyroid nodules

  • 摘要: 近年来,甲状腺结节的发病率逐年上升,高分辨率超声和超声引导下细针穿刺细胞学检查(fine needle aspiration biopsy,FNAB)是甲状腺结节术前诊断的最佳手段。但是仍然有一部分结节诊断不明确,于是FNAB结合甲状腺结节细针穿刺分子标志物的研究迅速发展。目前研究较多的分子标志物主要为BRAF基因突变、RAS基因突变、RET/PTC基因重排和PAX8/PPARγ基因重排等;以及使用免疫组织化学(immunohistochemistry,IHC)检测的半乳糖凝集素3(galectin-3,Gal-3)、细胞角蛋白19(cytokera? tin-19,CK-19)、人类骨髓内皮细胞(human bone marrow endothelial cell-1,HBME-1)等。本文对目前甲状腺结节细针穿刺(fine needle aspiration,FNA)分子标志物的一些研究进展进行综述。

     

    Abstract: Recently, the incidence of thyroid nodules has been annually increasing. High-resolution ultrasound and ultrasound-guided fine needle aspiration biopsy (FNAB) are the best means for preoperative diagnosis of thyroid nodules. However, the diagnosis of some nodules remains unclear. Hence, the use of FNAB bound to aspirate molecular markers in thyroid nodule has been developing rapidly. Currently, the major molecular markers studied are: mutations in BRAF and RAS genes, rearrangements in RET/PTC and PAX8/PPARγ genes; immunohistochemistry-based detection of galectin 3 (Gal-3), cytokeratin-19 (CK-19), human bone marrow endothelial cell-1 (HBME-1), etc. This review summarized the latest progress on molecular markers of fine needle aspiration biopsy of thyroid nodules.

     

/

返回文章
返回